Page 4 - Pooled Analysis News Today

– Pivotal Phase III data will be spotlighted via an oral presentation – – Additional efficacy and safety data will be featured across four posters – ... | June 18, 2023

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that two scientific abstracts on the clinical...

Three late-breaking presentations in vitiligo highlight new long-term data from the Phase 3 TRuE-V trials for Opzelura (ruxolitinib) cream and results from a Phase 2b study with povorcitinib (INCB54707)

21 scientific presentations, including 7 late breakers, showcase the breadth of UCBs portfolio, reinforcing commitment to improving the lives of people living...

PhasED-Seq ctDNA detection enables accurate and predictive treatment response monitoring and clinical prognosis in patients with B-cell lymphoma.A...

/PRNewswire/ -- Foresight Diagnostics, a leader in minimal residual disease (MRD) detection technology, announced today that three studies utilizing their...

/PRNewswire/ -- Trend Micro Incorporated (TYO: 4704;TSE: 4704), a global cybersecurity leader, today announced earnings results for the third quarter of fiscal...

NORWAY: Sigmoidoscopy screening reduces colorectal cancer (CRC) incidence and death significantly and sustainably over 15 years, according to a pooled analysis of randomized trials that was published...

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 13 abstracts will be presented at the American Society of Hematology (ASH) Annual...

Key data includes results for intravenous administration of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients DUBLIN